potassium chloride has been researched along with citalopram in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, T; Katsuragi, T; Mori, R | 1 |
| Bonanno, G; Raiteri, M | 1 |
| Bendotti, C; Fumagalli, F; Prosperini, E; Rizzi, M; Samanin, R; Tarizzo, G | 1 |
| Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hjorth, S; Wikell, C | 1 |
| Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
| Blier, P; Guiard, BP; Mansari, ME; Murphy, DL | 1 |
6 other study(ies) available for potassium chloride and citalopram
| Article | Year |
|---|---|
Release of purines and noradrenaline from the vascular adrenergic nerves by 5- and 6-hydroxydopamine.
Topics: Adenosine; Animals; Calcium; Citalopram; Hydroxydopamines; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Norepinephrine; Oxidopamine; Potassium Chloride; Propylamines; Pulmonary Artery; Purines; Rabbits; Serotonin Antagonists | 1987 |
Interaction between 5-HT uptake inhibition and activation of 5-HT autoreceptors by exogenous agonists in rat cerebral cortex slices and synaptosomes.
Topics: Animals; Calcium; Cerebral Cortex; Citalopram; Electric Stimulation; In Vitro Techniques; Indoles; Male; Potassium Chloride; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Synaptosomes; Tetrodotoxin | 1987 |
Acute and chronic treatments with citalopram lower somatostatin levels in rat brain striatum through different mechanisms.
Topics: Animals; Blotting, Northern; Citalopram; Corpus Striatum; Dose-Response Relationship, Drug; Male; Nucleus Accumbens; Potassium Chloride; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Somatostatin; Tetrodotoxin; Veratridine | 1997 |
Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency.
Topics: Animals; Antidepressive Agents; Biotransformation; Brain Chemistry; Citalopram; Extracellular Space; Hepatic Encephalopathy; Hydroxyindoleacetic Acid; Injections; Injections, Subcutaneous; Male; Microdialysis; Neocortex; Potassium Chloride; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin | 1997 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
Topics: Action Potentials; Animals; CA3 Region, Hippocampal; Central Nervous System Agents; Citalopram; Dorsal Raphe Nucleus; Extracellular Space; Hippocampus; Male; Mice, Transgenic; Neurons; Piperazines; Potassium Chloride; Pyramidal Cells; Pyridines; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Time Factors | 2012 |